BioSpace News Archive

Business

Vyripharm Enterprises Inc and ABB, Inc. collaborate on the design and development of Automation and Robotics to advance Testing Laboratory Platform for Public Health and Public Safety

Vyripharm Enterprises Inc. and ABB Robotics have signed an agreement towards the development of an automated laboratory testing platform.

October 17, 2022
·
4 min read
Bio NC

Biohope and C. Alan Foundation Named Winners of the 2022 Lyfebulb-Veloxis Innovation Challenge: Transforming Organ Transplantation

Lyfebulb and Veloxis Pharmaceuticals are excited to announce that Biohope was selected as the winner of the Innovation Award and C. Alan Foundation as the winner of the Impact Award at the 2022 Lyfebulb-Veloxis Innovation Challenge: Transforming Organ Transplantation.

October 17, 2022
·
4 min read
Pharm Country

Plexision offers the first rapid blood test panel to predict cytomegalovirus infection and transplant rejection

Plexision, a biotechnology company, is offering the first blood test panel capable of reporting the risk of cytomegalovirus infection and transplant rejection within six hours after samples arrive at its reference laboratory.

October 17, 2022
·
2 min read
Business

Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics’ Clinical Advisory Board

Selux Diagnostics announced today that Dr. James S. Lewis, PharmD, FIDSA, has joined as Chair of its Clinical Advisory Board.

October 17, 2022
·
3 min read
Genetown

OSSIO Closes Series C Financing of $38.5 Million

OSSIO , Ltd., a fast-growing orthopedic fixation technology company, announced today that it has closed $38.5 million in Series C financing.

October 17, 2022
·
3 min read
Policy

FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS

The U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in funding over the next four years to support clinical trials, natural history studies and regulatory science tools related to rare diseases.

October 17, 2022
·
5 min read
BioIVT Opens New Blood Donor Center in Glasgow, Scotland

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe

October 17, 2022
·
2 min read
SpectronRx Completes Critical Step in Path to Supplying Europe With Life-Saving Radiopharmaceuticals

Indiana-based radiopharmaceutical developer and manufacturer completes FDA inspection on behalf of the European Medicines Agency (EMA)

October 17, 2022
·
3 min read
Pharm Country

New Biotechnology Combines Targeted and Immune Therapies to Kill Treatment-resistant Cancer Cells

Targeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly evolve to thwart their action.

October 17, 2022
·
6 min read
Marvel Biosciences Successfully Completes Maximum Tolerated Dose Study, a Critical Milestone Towards FDA Clinical Studies

Marvel Biosciences Inc. (TSXV: MRVL) (the “Company” or “Marvel”) is pleased to announce it has completed its maximum tolerated dose (MTD) toxicology study for its product MB-204, validating its low toxicity.

October 17, 2022
·
4 min read